734. Dibutyryl cAMP stimulates the proliferation of SH-SY5Y human neuroblastoma cells by up-regulating Skp2 protein.
Cho CH, Seo M, Lee YI, Kim SY, Youn HD, Juhnn YS.
J Cancer Res Clin Oncol. 2007 Feb;133(2):135-44. Epub 2006 Sep 27Link
733. Inhibition of gamma ray-induced apoptosis by stimulatory heterotrimeric GTP binding protein involves Bcl-xL down-regulation in SH-SY5Y human neuroblastoma cells.
732. G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.
Seo M, Lee MJ, Heo JH, Lee YI, Kim Y, Kim SY, Lee ES, Juhnn YS.
J Biol Chem. 2007 Aug 24;282(34):24720-30. Epub 2007 Jun 4Link
731. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading.
Shin DH, Kim JH, Jung YJ, Kim KE, Jeong JM, Chun YS, Park JW.
Cancer Lett. 2007 Sep 18;255(1):107-16. Epub 2007 May 14Link
730. CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition.
Shin DH, Li SH, Chun YS, Huang LE, Kim MS, Park JW.
729. ATP6V0C competes with von Hippel-Lindau protein in hypoxia-inducible factor 1alpha (HIF-1alpha) binding and mediates HIF-1alpha expression by bafilomycin A1.
Lim JH, Park JW, Kim SJ, Kim MS, Park SK, Johnson RS, Chun YS.
Mol Pharmacol. 2007 Mar;71(3):942-8. Epub 2006 Dec 18Link
728. HIF-1alpha promotes survival of prostate cells at a high zinc environment.
Park SE, ParK JW, Cho YS, Ryu JH, Paick JS, Chun YS,